Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2014
10/01/2014EP2782563A1 Phytocannabinoids for use in the treatment of intestinal inflammatory diseases
10/01/2014EP2782562A2 Natural-killer/t-cell lymphoma (nktcl) susceptibility prediction, diagnosis and therapy
10/01/2014EP2782561A1 Controlled release particles comprising dimethyl fumarate
10/01/2014EP2782560A1 Imatinib solid dosage forms reconstituted just before use
10/01/2014EP2782559A1 Pharmaceutical composition comprising myo-inositol and d-chiro-inositol
10/01/2014EP2782558A1 Immediate release abuse deterrent tablet
10/01/2014EP2782448A1 Boron-containing small molecules
09/2014
09/30/2014USRE45174 Thiazolidin-4-one derivatives
09/30/2014USRE45173 Inhibitors of CYP 17
09/30/2014US8849441 Systems, devices, and methods for making or administering frozen particles
09/30/2014US8846976 Ferric organic compounds, uses thereof and methods of making same
09/30/2014US8846972 Fatty acid acylated salicylates and their uses
09/30/2014US8846951 Modulators of 5-HT receptors and methods of use thereof
09/30/2014US8846949 Pyrrolopyrazoles as N-type calcium channel blockers
09/30/2014US8846948 Compounds
09/30/2014US8846947 Benzimidazoles and related analogs as sirtuin modulators
09/30/2014US8846937 Mono quaternary ammonium salts and methods for modulating neuronal nicotinic acetylcholine receptors
09/30/2014US8846936 Sulfonyl compounds which modulate the CB2 receptor
09/30/2014US8846934 Substituted oxazolidinones and their use
09/30/2014US8846933 N-link hydroxamic acid derivatives useful as antibacterial agents
09/30/2014US8846932 Small molecules modulator of epigenetic regulation and their therapeutic applications
09/30/2014US8846931 Bipyridyl derivatives
09/30/2014US8846930 Derivatives of heteroarylsulfonamides, their preparation and their application in human therapy
09/30/2014US8846918 Compounds useful as inhibitors of ATR kinase
09/30/2014US8846917 Compounds useful as inhibitors of ATR kinase
09/30/2014US8846914 Compositions to effect neuronal growth
09/30/2014US8846910 Matrix metalloproteinase inhibitors
09/30/2014US8846909 Bicyclic heteroaryl kinase inhibitors and methods of use
09/30/2014US8846908 Tricyclic carbamate JAK inhibitors
09/30/2014US8846906 5HT2C receptor modulators
09/30/2014US8846900 Cellulose diacetate for retardation film
09/30/2014US8846896 Methods of preparing substituted nucleotide analogs
09/30/2014US8846893 Non-ionically bound constructs, and compositions and kits comprising domains
09/30/2014US8846889 Peptide biosynthesis and pain therapy
09/30/2014US8846876 Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
09/30/2014US8846859 Compositions and methods of use of targeting peptides against placenta and adipose tissues
09/30/2014US8846836 Hyaluronic acid based copolymers
09/30/2014US8846771 Compositions and methods of delivery of pharmacological agents
09/30/2014US8846770 Controlled release aural pressure modulator compositions and methods for the treatment of OTIC disorders
09/30/2014US8846768 Use of compounds isolated from Euphorbia neriifolia for treating cancer and/or thrombocytopenia
09/30/2014US8846766 Abuse-deterrent methadone for the safe treatment of drug abuse and pain relief
09/30/2014US8846765 Pharmaceutical combination
09/30/2014US8846764 Methods of modulating cell proliferation and cyst formation in polycystic kidney and liver diseases
09/30/2014US8846763 High purity 2-[4-(3- or 2-fluorobenzyloxy)benzylamino] propanamides and methods of use thereof
09/30/2014US8846762 Benzopyran and benzoxepin PI3K inhibitor compounds and methods of use
09/30/2014US8846761 Method for treating pancreatitis
09/30/2014US8846760 Dihydronaphthalene and naphthalene derivatives as N-formyl peptide receptor like-1 (FPRL-1) receptor modulators
09/30/2014US8846759 Low-caloric high-protein nutritional composition for the stimulation of muscle protein synthesis
09/30/2014US8846758 Methods of decreasing glycosylated hemoglobin in patients with dyslipidemia
09/30/2014US8846757 Bioactive depside and anthocyanin compounds, compositions, and methods of use
09/30/2014US8846756 Substituted acylanilides and methods of use thereof
09/30/2014US8846755 Sulfonamides for the prevention of diabetes
09/30/2014US8846754 Azeotrope-like compositions of cis-1,1,1,4,4,4-hexafluoro-2-butene
09/30/2014US8846753 Modulators of ATP-binding cassette transporters
09/30/2014US8846752 Isoflavone fatty acid ester derivatives, preparation method and pharmaceutical uses thereof
09/30/2014US8846751 Agent for inhibiting production of hepatitis C virus and its use
09/30/2014US8846750 Pharmaceutical and food compositions for preventing or treating diabetes or obesity
09/30/2014US8846749 Anticancer-aiding compound, method for preparing the same, anticancer-aiding composition containing the same and method for reducing anticancer drug resistance using the same
09/30/2014US8846748 Indolyl or indolinyl hydroxamate compounds
09/30/2014US8846747 Compounds and methods for altering lifespan of eukaryotic organisms
09/30/2014US8846746 Pyrazole compound and pharmaceutical use thereof
09/30/2014US8846745 Use of an indazolemethoxyalkanoic acid for reducing triglyceride, cholesterol and glucose levels
09/30/2014US8846744 Pharmaceutical compositions of co-crystals of tramadol and coxibs
09/30/2014US8846743 Aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy
09/30/2014US8846742 Neuronal pain pathway modulators
09/30/2014US8846741 N-substituted aminobenzocycloheptene, aminotetraline, aminoindane and phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
09/30/2014US8846739 TGR5 agonists
09/30/2014US8846738 Fungicide active substance combinations
09/30/2014US8846736 Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents
09/30/2014US8846735 Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases
09/30/2014US8846734 Diazonamide analogs
09/30/2014US8846732 Inhibition of biogenic sulfide production via biocide and metabolic inhibitor combination
09/30/2014US8846731 Salts and polymorphs of desazadesferrithiocin polyether analogues as metal chelation agents
09/30/2014US8846730 Compounds as cannabinoid receptor ligands
09/30/2014US8846729 2-thio-1,3,4-oxadiazoles azetidine derivatives as sphingosine-1 phosphate receptors modulators
09/30/2014US8846728 Oxadiazole derivatives as sphingosine 1-phosphate (S1P) receptor modulators
09/30/2014US8846727 Haloalkyl heteroaryl benzamide compounds
09/30/2014US8846726 Modulators of indoleamine 2,3-dioxygenase and methods of using the same
09/30/2014US8846725 Highly penetrating compositions and methods for treating pathogen-induced disordered tissues
09/30/2014US8846724 Compositions for treating obesity and insulin resistance disorders
09/30/2014US8846723 Esters of O-substituted hydroxy carboxylic acids and preparations thereof
09/30/2014US8846722 Animal parasite-control method using insect growth regulators
09/30/2014US8846721 Compositions for reducing aβ 42 production and their use in treating alzheimer's disease (AD)
09/30/2014US8846719 Isoxazolo-pyridine derivatives
09/30/2014US8846718 Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxo1-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid
09/30/2014US8846717 Stable insecticide compositions and methods for producing same
09/30/2014US8846715 (2S,3R)-N-(2((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)benzofuran-2-carboxamide novel salt forms, and methods of use thereof
09/30/2014US8846714 1H-pyrazolo[3,4-β]pyridines and therapeutic uses thereof
09/30/2014US8846713 Fused heterocyclic compounds as phosphodiesterases (PDEs) inhibitors
09/30/2014US8846712 6-(4-hydroxy-phenyl)-3-styryl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
09/30/2014US8846711 Heterocyclic acrylamides and their use as pharmaceuticals
09/30/2014US8846710 Method of preferentially inducing the biosynthesis of interferon
09/30/2014US8846709 7-(3,5-dimethyl-4-isoxazolyl)-8-(methyloxy)-1H-imidazo[4,5-C]quinoline derivatives
09/30/2014US8846708 Salt of a pyrimidin derivative
09/30/2014US8846707 Substituted 2-hydroxy-4-(2-(phenylsulfonamido)acetamido)benzoic acid analogs as inhibitors of stat protein
09/30/2014US8846706 Crystalline form K of imatinib mesylate
09/30/2014US8846705 Diaminopyrimidines as P2X3 and P2X2/3 antagonists
09/30/2014US8846704 Thiopyrimidine-based compounds and uses thereof
09/30/2014US8846703 Crystal of a free tricyclic pyrazolopyrimidine derivative
09/30/2014US8846702 Pyranyl aryl methyl benzoquinazolinone M1 receptor positive allosteric modulators